TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
NKTX

Nkarta Inc

Healthcare · Biotechnology

2.60$ +0.6% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Nkarta Inc (NKTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 338 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet NKTX
Line item Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
– – – 48 41 44 352 338 326 309 292 274 306 504 504 473 458 429 406 379 577 554 532 501 471 448 427 404 372 338
7.9 – – 37 26 22 333 319 302 284 265 246 223 417 401 361 332 287 281 253 443 332 290 273 272 297 289 283 236 188
-7.9 – – 21 17 18 189 97 63 24 96 61 42 132 40 37 54 29 38 31 250 120 57 28 53 53 60 40 27 25
7.9 – – 37 26 22 330 315 299 280 258 238 217 413 392 352 323 281 276 248 437 325 283 267 266 290 282 276 230 183
– – – – – – – – – – – – – – – 1.3 – – – 0.2 1.3 2.1 2.5 0.2 2.4 2.2 2.1 2.0 1.7 –
– – – – – – – – – – – – – – – -4.2 – – – – – – – – – – – – – –
– – – – 13 17 18 18 22 23 24 13 14 17 30 62 70 117 – – – – – – – – – – – –
– – – 74 15 68 17 16 20 21 22 23 78 83 105 101 112 111 109 106 103 101 101 93 92 91 89 92 86 90
– – – 8.2 9.3 60 9.6 8.8 9.4 10 12 13 11 13 26 22 26 27 26 23 22 21 22 19 19 19 19 22 18 24
– – – 1.5 1.6 12 1.5 1.4 2.2 2.3 2.5 2.5 2.5 3.1 5.4 4.2 5.8 6.1 6.1 6.1 6.1 5.5 6.8 6.1 6.0 6.9 6.4 6.9 7.1 7.3
– – – 1.9 2.0 1.7 2.3 1.2 2.0 2.2 2.1 1.1 2.0 3.0 9.5 1.8 5.4 3.0 4.3 3.7 3.2 3.8 1.9 0.6 1.5 1.5 1.4 2.1 1.6 3.8
7.3 – – -25 26 -24 335 321 306 288 270 251 229 421 399 372 347 318 297 273 474 453 431 408 379 358 338 312 286 248
– – – -27 -35 -86 -100 -118 -137 -159 -181 -204 -230 -257 -285 -318 -349 -382 -408 -435 -465 -490 -518 -544 -576 -599 -621 -648 -676 -717
9.0 9.0 9.0 9.0 29 30 31 33 33 33 33 33 33 44 49 49 49 49 49 49 51 73 74 74 74 74 74 74 74 74

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?